Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00537745 · ClinicalTrials.gov registry record · Phase 4

Vivitrol for Reducing Driving While Impaired Behavior Among Repeat Offenders

A Phase 4 study, sponsored by Pacific Institute for Research and Evaluation.

Completed
Registry status
Phase 4
Development phase
14
Enrollment target

NCT00537745 is a Phase 4 study that has completed, run by Pacific Institute for Research and Evaluation. The registered enrollment target is 14 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00537745, a Phase 4 study, has completed, sponsored by Pacific Institute for Research and Evaluation.

COMPLETED
Registry status
Phase 4
Development phase
14 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether Vivitrol is effective at reducing attempts to drive after drinking among repeat driving while intoxicated (DWI) offenders with Ignition Interlock devices.

Interventions

  • DRUG Vivitrol (Medication Therapy)
  • OTHER Medication Management Therapy

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2007-04
Est. Completion 2009-05
Phase Phase 4

What the Registry Record Tells You About NCT00537745

The ClinicalTrials.gov registry entry for NCT00537745 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pacific Institute for Research and Evaluation, which has 10 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Vivitrol (Medication Therapy) is the first listed.

NCT00537745 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00537745 about?

NCT00537745 is a clinical study titled "Vivitrol for Reducing Driving While Impaired Behavior Among Repeat Offenders". The purpose of this study is to determine whether Vivitrol is effective at reducing attempts to drive after drinking among repeat driving while intoxicated (DWI) offenders with Ignition Interlock devices.

What is the current status of trial NCT00537745?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 14 participants. The study started on 2007-04. Estimated completion is 2009-05.

What interventions are being tested in trial NCT00537745?

The interventions under investigation include: Vivitrol (Medication Therapy) (DRUG), Medication Management Therapy (OTHER).

Who is sponsoring clinical trial NCT00537745?

This trial is sponsored by Pacific Institute for Research and Evaluation, which has 10 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.